State Of Wyoming Mirum Pharmaceuticals, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$18.42 - $27.5 $10,223 - $15,262	555 Added 254.59%	773 $15,000
Q1 2022 May 13, 2022	BUY	$15.5 - $23.93 $2,836 - $4,379	183 Added 522.86%	218 $5,000
Q4 2021 Feb 11, 2022	SELL	$13.05 - $19.35 $26 - $38	-2 Reduced 5.41%	35 $1,000
Q3 2021 Feb 11, 2022	SELL	$13.95 - $20.18 $251 - $363	-18 Reduced 32.73%	37 $1,000
Q2 2021 Feb 11, 2022	BUY	$15.84 - $20.6 $871 - $1,133	55 New	55 $1,000

211

53.8M

2.6K

99.7K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.63B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.